Ignite Creation Date:
2025-12-24 @ 3:53 PM
Ignite Modification Date:
2026-02-02 @ 4:48 PM
Study NCT ID:
NCT03882892
Status:
COMPLETED
Last Update Posted:
2024-05-10
First Post:
2019-03-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Long-Term Safety and Tolerability of Ezetimibe (SCH 58235, MK-0653) With Atovastatin (P02154, MK-0653-017)
Sponsor:
Organon and Co
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-02-02
Start Date Type:
ACTUAL
Primary Completion Date:
2002-08-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2002-08-08
Completion Date Type:
ACTUAL
First Submit Date:
2019-03-19
First Submit QC Date:
None
Study First Post Date:
2019-03-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-08
Last Update Post Date:
2024-05-10
Last Update Post Date Type:
ACTUAL